Kottai Suresh Ranganathan
About Kottai Suresh Ranganathan
Kottai Suresh Ranganathan has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Zota Pharmaceuticals Private Limited and Buena Pharma Private Limited. Formerly with 3 companies, such as Rhys Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zota Pharmaceuticals Private Limited
U24231TN2003PTC050612
|
Director | 28 Mar 2003 | 2003 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rhys Healthcare Private Limited
U73100TN2008PTC066892
|
Additional Director | 08 Sep 2009 | 2008 | Strike Off |
Buena Pharma Private Limited
U51397TN2005PTC057423
|
Director | 08 Sep 2005 | 2005 | Strike Off |
Unico Healthcare Private Limited
U74900TN2011PTC082021
|
Director | 23 Aug 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kottai Suresh Ranganathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kottai Suresh Ranganathan
Kottai Suresh Ranganathan has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Zota Pharmaceuticals Private Limited and Buena Pharma Private Limited. Formerly with 3 companies, such as Rhys Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Kottai Suresh Ranganathan is associated with 1 company as Director.
Kottai Suresh Ranganathan has expertise in General Business, Healthcare.
Kottai Suresh Ranganathan has 23 years in corporate governance.